Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Receivables - Other: 2017-2021

  • Mimedx Group's Receivables - Other was N/A to $400,000 in Q2 2021 from the same period last year, while for Jun 2021 it was $400,000, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2020, which is 84.62% down from last year.
  • Latest data reveals that Mimedx Group reported Receivables - Other of $400,000 as of Q2 2021, which was down 42.86% from $700,000 recorded in Q1 2021.
  • Over the past 5 years, Mimedx Group's Receivables - Other peaked at $5.9 million during Q4 2017, and registered a low of $200,000 during Q4 2020.
  • Over the past 3 years, Mimedx Group's median Receivables - Other value was $650,000 (recorded in 2020), while the average stood at $935,333.
  • Its Receivables - Other has fluctuated over the past 5 years, first slumped by 84.62% in 2020, then grew by 16.67% in 2021.
  • Mimedx Group's Receivables - Other (Quarterly) stood at $5.9 million in 2017, then dropped by 27.12% to $4.3 million in 2018, then plummeted by 69.77% to $1.3 million in 2019, then crashed by 84.62% to $200,000 in 2020, then rose by 16.67% to $400,000 in 2021.
  • Its last three reported values are $400,000 in Q2 2021, $700,000 for Q1 2021, and $200,000 during Q4 2020.